Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ homolog subfamily C member 2 (DNAJC2) is a multifunctional protein belonging to the heat shock protein 40 (Hsp40) family, specifically the M-phase phosphoprotein (MPP) family, characterized by a J domain and a Myb-type DNA-binding domain[1][3][4]. It functions as both a molecular chaperone—where it forms heterodimers with ribosome-associated complexes to aid the folding and maturation of nascent polypeptides—and a chromatin regulator, with roles in transcriptional activation by binding ubiquitinated histone H2A to displace Polycomb repressive complexes, thus facilitating activation of tumor suppressor genes[1][3][5]. DNAJC2 acts in both the nucleus and cytosol, is essential during embryonic development, and has been linked to several cancers and proliferative disorders, with upregulation in leukemic blasts and colorectal cancer among others[1][3][4][5]. Dysregulation of DNAJC2 has been associated with oncogenic processes, and the gene is considered a potential therapeutic target as well as a biomarker for certain malignancies[1][3].\n\nNo approved drugs or direct small-molecule inhibitors targeting DNAJC2 are documented in open sources[3][4], and established mechanisms of pharmacological modulation have not been described.\n\nIf you need more details (such as specific list of interacting proteins or further disease associations), please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ homolog subfamily C member 2 (DNAJC2).